The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19

OBJECTIVE: During the COVID-19 pandemic the continuation or cessation of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) has been contentious. Mechanisms have been proposed for both beneficial and detrimental effects. Recent studies have focused on mortality...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Cardiol Heart Vasc
Päätekijät: Braude, Philip, Carter, Ben, Short, Roxanna, Vilches-Moraga, Arturo, Verduri, Alessia, Pearce, Lyndsay, Price, Angeline, Quinn, Terence J., Stechman, Michael, Collins, Jemima, Bruce, Eilidh, Einarsson, Alice, Rickard, Frances, Mitchell, Emma, Holloway, Mark, Hesford, James, Barlow-Pay, Fenella, Clini, Enrico, Myint, Phyo Kyaw, Moug, Susan, McCarthy, Kathryn, Hewitt, Jonathan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2020
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7561344/
https://ncbi.nlm.nih.gov/pubmed/33083516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100660
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia